Guides & Guidelines

ANNALS
Nov 23, 2023
AL amyloidosis: Singapore Myeloma Study Group consensus guidelines on diagnosis, treatment and management
AL amyloidosis is the most common form of systemic amyloidosis. However, the non-specific nature of presenting symptoms requires the need for a heightened clinical…
Read more
Jun 01, 2022
Guidelines and New Directions in the Therapy and Monitoring of ATTRv Amyloidosis
The recent approval of three drugs for the treatment of amyloid transthyretin (ATTR) amyloidosis, both hereditary and wild-type, has opened a new era in the care of…
Read more
Nov 15, 2021
Guidelines for High Dose Chemotherapy and Stem Cell Transplantation for Systemic AL Amyloidosis: EHA-ISA Working Group Guidelines
AL amyloidosis is a systemic amyloidosis and is associated with an underlying plasma cell dyscrasia. High dose intravenous melphalan and autologous stem cell…
Read more
May 17, 2021
Comprehensive Review of AL Amyloidosis: Some Practical Recommendations
Amyloid light chain (AL) amyloidosis is among the more common and more severe of the amyloidoses usually involving the slow proliferation of a bone-marrow-residing…
Read more
ISA Guidelines
ISA Guidelines
ISA GuidelinesTissue Biopsy for the Diagnosis of Amyloidosis: Experience From Some Centres external link, opens in a new tab(paper from ISA’s Tissue Diagnosis…
Read more
Subscribe to